A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Genmab
National Institutes of Health Clinical Center (CC)
Gilead Sciences
Newave Pharmaceutical Inc
City of Hope Medical Center
City of Hope Medical Center
MacroGenics
Acerta Pharma BV
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Stanford University
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
University of California, Davis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Xencor, Inc.
Astellas Pharma Inc
Mustang Bio
City of Hope Medical Center
Stanford University
University of Nebraska
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
Rutgers, The State University of New Jersey
Northwestern University
Northwestern University
University Hospital, Strasbourg, France
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)